- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00808496
The Effect of Biannual Monitoring With Magnetic Resonance Imaging (MRI), X-ray, or Usual Care on Treatment for Inflammatory Arthritis (MRx)
A Double Blind Randomized Controlled Trial to Compare Biannual Peripheral Magnetic Resonance Imaging, Radiography, and Standard of Care on Pharmacotherapeutic Escalation in Inflammatory Arthritis
Inflammatory arthritis is a major cause of permanent joint damage. Joint damage causes functional disability and physical deformity. Many inflammatory arthritis patients develop permanent joint damage within the first two years of disease. Early, aggressive treatment with drugs called disease-modifying antirheumatic drugs (DMARDs) is known to reduce how quickly this damage occurs. Sometimes, however, even when patients' symptoms are under control, the disease continues to cause joint damage.
This study will determine if magnetic resonance imaging (also known as 'MRI') conducted every six months provides arthritis specialists with information to help them better treat peripheral inflammatory arthritis patients over the first two years of care. The effect of MRI will be compared to 1) the use of x-ray every six months; and, 2) the frequency at which these tests are usually used. The study will also determine if differences in treatment between the three groups result in differences in the well-being of patients.
A total of 186 patients with early signs of inflammatory arthritis will be studied. All participants will have an MRI and x-ray conducted every six months. One-third of participants (62 in total) will only have MRI information sent to their arthritis specialist (MRI group); 62 will have x-ray information sent (X-ray group); and, the remaining 62 will have x-ray information sent only when ordered by the arthritis specialist (Usual Care group). Negative disease progression reports will be sent to the arthritis specialist unless intervention allocation-specific disease progression is detected. In which case, a report blinded to imaging modality will be sent indicating the detection of disease progression relative to the last timepoint of progression, or baseline, as applicable. At any point in the study, the arthritis specialist can request a clinical MRI or x-ray for any participant.
Neither the participants nor their doctors will know to which group they are assigned. A computer program will randomly assign participants to one of the three groups using a technique called minimization. This technique accounts for differences between participants that are known to effect disease progression and treatment decisions. Using this technique, participants with similar disease will be evenly distributed between the three groups.
The results of this study will have a direct impact on care for new inflammatory arthritis patients. It will determine the benefits, if any, of regular monitoring of disease progression with MRI or x-ray. Using tests proven to help treatment decision-making, arthritis specialists will improve the care provided to new inflammatory arthritis patients.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Forventet)
Fase
- Fase 4
Kontakter og plasseringer
Studiesteder
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 1Y2
- McMaster University, Division of Rheumatology
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- At least 18 years of age at study enrollment.
- At least three swollen joints; OR,
- Metacarpophalangeal joint(s) positive squeeze test; OR,
- Metatarsophalangeal joint(s) positive squeeze test; OR,
- At least 30 minutes of self-reported morning stiffness.
- At least six weeks of self-reported symptom duration.
Exclusion Criteria:
- Self-reported symptom onset prior to 17 years of age.
- Medical history of juvenile arthritis
- Evidence of viral arthritis
- A concomitant condition with medical priority over inflammatory arthritis, or that contraindicates treatment with DMARDs excluding sulfa allergy or medically controlled, non-terminal liver disease.
- Refusal to receive DMARD treatment
- Patients with a psychological deficit, or diminished capacity to provide independent, informed consent
- Any contraindication to MRI or x-ray
- Current or planned pregnancy
- Lactation
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Diagnostisk
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: MRI
Biannual disease progression monitoring with peripheral magnetic resonance imaging of the 2nd to 5th metacarpophalangeal joints of the worst-effected or dominant hand at baseline.
|
Biannual disease progression monitoring with peripheral magnetic resonance imaging of the 2nd to 5th metacarpophalangeal joints of the worst-effected or dominant hand at baseline. Scored using the Xie-modified rheumatoid arthritis magnetic resonance imaging score (RAMRIS). MRI intervention group also undergoes radiography imaging. Only protocol determined smallest detectable changes on MRI reported.
Andre navn:
|
Aktiv komparator: Radiography
Biannual disease progression monitoring with radiography of both hands and wrists.
|
Biannual disease progression monitoring with radiography of both hands and wrists. Scored using the van der Heijde-modified Sharp score. Radiography intervention group also undergoes MRI imaging. Only protocol determined smallest detectable changes on radiography reported.
Andre navn:
|
Placebo komparator: Standard of Care
Diagnostic imaging results (MRI or radiography) reported to upon requisition.
|
Diagnostic imaging results (MRI or radiography) reported upon requisition.
Standard of Care intervention group undergoes both MRI and radiography imaging.
Upon requisition of either MRI or radiography, radiology reports are delivered as per institutional standard of care
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
The frequency of antirheumatic treatment escalations.
Tidsramme: Two years
|
Two years
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
---|---|
Change in van der Heijde-modified Sharp score of the hands and feet.
Tidsramme: Two years
|
Two years
|
Change in 28-joint disease activity score (DAS28)
Tidsramme: Two years
|
Two years
|
Change in health assessment questionnaire (HAQ) score
Tidsramme: Two years
|
Two years
|
Change in Xie-modified rheumatoid arthritis magnetic resonance imaging score (RAMRIS)
Tidsramme: Two years
|
Two years
|
Change in health utility index - mark 3 (HUI-III)
Tidsramme: Two years
|
Two years
|
Change in EQ-5D
Tidsramme: Two years
|
Two years
|
Number of smallest detectable changes
Tidsramme: Two years
|
Two years
|
Change in the proportion of participants with radiography-determined erosions of the hands, wrists, or feet
Tidsramme: Two years
|
Two years
|
Change in the number of radiography-determined erosions of the hands, wrists or feet
Tidsramme: Two years
|
Two years
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Ruben Tavares, MBt MSc CCRA, McMaster University
- Studiestol: Jonathan D Adachi, MD FRCPC, McMaster University
- Studieleder: Maggie J Larche, MD PhD, McMaster University
- Studieleder: Colin E Webber, PhD CCPM, McMaster University
- Studieleder: Naveen Parasu, MD FRCPC, McMaster University
- Studieleder: Karen A Beattie, PhD, McMaster University
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, Outman R, Allison JJ, Suarez Almazor M, Bridges SL Jr, Chatham WW, Hochberg M, MacLean C, Mikuls T, Moreland LW, O'Dell J, Turkiewicz AM, Furst DE; American College of Rheumatology. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008 Jun 15;59(6):762-84. doi: 10.1002/art.23721. No abstract available.
- Taves DR. Minimization: a new method of assigning patients to treatment and control groups. Clin Pharmacol Ther. 1974 May;15(5):443-53. doi: 10.1002/cpt1974155443. No abstract available.
- Brown AK, Conaghan PG, Karim Z, Quinn MA, Ikeda K, Peterfy CG, Hensor E, Wakefield RJ, O'Connor PJ, Emery P. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 2008 Oct;58(10):2958-67. doi: 10.1002/art.23945.
- Schiff MH, Hobbs KF, Gensler T, Keenan GF. A retrospective analysis of low-field strength magnetic resonance imaging and the management of patients with rheumatoid arthritis. Curr Med Res Opin. 2007 May;23(5):961-8. doi: 10.1185/030079907x178892.
- McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, McLean L. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis. 1999 Mar;58(3):156-63. doi: 10.1136/ard.58.3.156.
- Olech E, Freeston JE, Conaghan PG, Hensor EM, Emery P, Yocum D. Using extremity magnetic resonance imaging to assess and monitor early rheumatoid arthritis: the optimal joint combination to be scanned in clinical practice. J Rheumatol. 2008 Apr;35(4):580-3. Epub 2008 Mar 1.
- Xie X, Webber CE, Adachi JD, O'Neill J, Inglis D, Bobba RS, Wu H. Quantitative, small bore, 1 Tesla, magnetic resonance imaging of the hands of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008 Sep-Oct;26(5):860-5.
- van der Heijde DM, van Riel PL, Nuver-Zwart IH, Gribnau FW, vad de Putte LB. Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis. Lancet. 1989 May 13;1(8646):1036-8. doi: 10.1016/s0140-6736(89)92442-2.
- Emery P, Breedveld FC, Dougados M, Kalden JR, Schiff MH, Smolen JS. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann Rheum Dis. 2002 Apr;61(4):290-7. doi: 10.1136/ard.61.4.290.
- Tavares R, Beattie KA, Bensen WG, Bobba RS, Cividino AA, Finlay K, Goeree R, Hart LE, Jurriaans E, Larche MJ, Parasu N, Tarride JE, Webber CE, Adachi JD. A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial. Trials. 2014 Jul 5;15:268. doi: 10.1186/1745-6215-15-268.
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Forventet)
Studiet fullført (Forventet)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 200901
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Inflammatorisk leddgikt
-
University of ArkansasAvsluttetPediatriske pasienter med SIRS (Systemic Inflammatory Response Syndrome)Forente stater
-
Arkansas Children's Hospital Research InstituteEunice Kennedy Shriver National Institute of Child Health and Human Development...AvsluttetSIRS (Systemic Inflammatory Response Syndrome)Forente stater
-
Chinese PLA General HospitalFullførtSepsis | SIRS (Systemic Inflammatory Response Syndrome)Kina
-
Chinese PLA General HospitalUkjentSepsis | SIRS (Systemic Inflammatory Response Syndrome)Kina
-
Istanbul UniversityFullførtBetennelse | Type 2 diabetes | Medisinsk ernæringsterapi | Dietary inflammatory Index (DII)Tyrkia
Kliniske studier på MRI
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupUkjentBrystkreft | BIRADS 3 | BIRADS 4 | BIRADS 5Forente stater
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH)Aktiv, ikke rekrutterendeHode- og nakkekreftForente stater
-
The Hospital for Sick ChildrenPåmelding etter invitasjon
-
Assiut UniversityUkjentMultippel sklerose
-
Vanderbilt UniversityNational Institutes of Health (NIH)TilbaketrukketMR termisk avbildning av spedbarn som gjennomgår avkjøling for hypoksisk iskemisk encefalopati (HIE)Hypoksisk iskemisk encefalopatiForente stater
-
Fondation Ophtalmologique Adolphe de RothschildRekrutteringOptimaliserte MR-sekvenserFrankrike
-
Institut National de la Santé Et de la Recherche...Fullført
-
University of MilanFullført
-
Stanford UniversityColumbia University; University of ManchesterRekruttering
-
Washington University School of MedicineNational Institute of Neurological Disorders and Stroke (NINDS)RekrutteringSunn | Perifer nerveskade Øvre ekstremitetForente stater